What We're Reading: Page 267
Industry reads hand-picked by our editors
Apr 23, 2018
-
Nikkei Asian Review
Why Takeda has bet the farm on Shire
-
Financial Times
US companies count costs and benefits of Trump tax law
-
The New York Times
The problem with miracle cancer cures
Apr 20, 2018
Apr 19, 2018
-
Bloomberg
Chinese money floods U.S. biotech as Beijing chases new cures
-
Reuters
Industry fears disruption as EU excludes UK from drug approvals
-
The New York Times
The menopause-Alzheimer’s connection
-
NPR
Chasing a new way to prevent HIV: Passive immunization
-
The New Yorker
A stunning gene-therapy breakthrough in the fight against beta thalassemia, a devastating blood disease
Apr 18, 2018
-
The Boston Globe
Trade secrets battle between Alnylam, Dicerna is just one of many
-
Bloomberg
Glaxo, Novartis join $4 billion Gates-led push to fight malaria
-
The Washington Post
New CDC chief stepped down from four groups to comply with ethics rules
-
Reuters
Shire faces criticism on CEO pay policy as crunch week looms
Apr 17, 2018
-
Harvard Magazine
Targeting cancer
-
Financial Times
Gene tech offers fresh lines of attack against malaria
-
Genetic Engineering & Biotechnology News
Blood pressure drugs work best with musical accompaniment
Previous
